Trial Profile
The effects of zoledronic acid on serum sclerostin levels in patients with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 19 Sep 2013 New trial record